SEO URLwww.firestrike.ai/deals/arthrosi-therapeutics-sobi-acquisition-2026-1

acquisitionAnnounced · Feb 4, 2026PharmaceuticalSource · CredibleArticle · Factual

Arthrosi Therapeutics · Sobi

Sobi acquires Arthrosi Therapeutics

David Najork · Founding Software Engineer

Announced Feb 4, 2026 · Updated Apr 29, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

$1.5B

Target

Arthrosi Therapeutics

San Diego, California

Acquirer

Sobi

Full Acquisition

Status

Announced

Sobi agreed to acquire Arthrosi Therapeutics. Reported deal value: $1.5B. Status: Announced. Sector: Pharmaceutical. Target headquarters context: San Diego, California, United States.

This page summarizes publicly available information about the transaction as of 2026-02-04. Figures and status may change as filings and press coverage update.

Stockholm -based global biopharma company Swedish Orphan Biovitrum will acquire San Diego -based private late-stage biotechnology company Arthrosi Therapeutics

Deal timeline

Announced

Feb 4, 2026 · latimes.com

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in Pharmaceutical with a reported deal value of $1.5B. Figures and status may change as sources update.

Sources: latimes.com · Primary article · FireStrike proprietary index